STANFORD UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-11-11

Employees: 10K

Market Cap: -

Website: http://www.stanford.edu

Clinical Trials

T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020

Phase 4

Completed

Conditions: Herpes Zoster

Interventions: Biological: Zostavax™

First Posted Date: 2013-07-30

Last Posted Date: 2023-12-18

Lead Sponsor: Stanford University

Target Recruit Count: 54

Registration Number: NCT01911065

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Taste Reward Processing in Pediatric Obesity

Completed

Conditions: Pediatric Obesity

First Posted Date: 2013-07-25

Last Posted Date: 2019-04-10

Lead Sponsor: Stanford University

Target Recruit Count: 30

Registration Number: NCT01908153

Locations: 🇺🇸
Stanford University Department of Psychiatry, Stanford, California, United States

Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions

Not Applicable

Completed

Conditions: Kidney Tumor
Adult Primary Liver Cancer

Interventions: Procedure: ultrasound elasticity imaging

First Posted Date: 2013-07-25

Last Posted Date: 2017-06-08

Lead Sponsor: Stanford University

Target Recruit Count: 61

Registration Number: NCT01908166

Locations: 🇺🇸
Stanford University, School of Medicine, Stanford, California, United States

Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1

Terminated

Conditions: Adult Acute Megakaryoblastic Leukemia (M7)
Adult Acute Monoblastic Leukemia (M5a)
Adult Acute Monocytic Leukemia (M5b)
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Adult Acute Myeloid Leukemia With Del(5q)
Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
Adult Pure Erythroid Leukemia (M6b)
Adult Acute Myeloblastic Leukemia With Maturation (M2)
Adult Acute Myeloblastic Leukemia Without Maturation (M1)
Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)

Interventions: Drug: lenalidomide
Drug: mitoxantrone hydrochloride
Drug: etoposide
Drug: cytarabine

First Posted Date: 2013-07-22

Last Posted Date: 2018-10-29

Lead Sponsor: Stanford University

Target Recruit Count: 17

Registration Number: NCT01904643

Locations: 🇺🇸
Stanford University, School of Medicine, Stanford, California, United States

Safety and Efficacy of Probiotics in Bangladeshi Infants

Phase 1

Completed

Conditions: Healthy

Interventions: Dietary Supplement: Lactobacillus reuteri DSM 17938
Dietary Supplement: Bifidobacterium longum infantis

First Posted Date: 2013-07-15

Last Posted Date: 2016-10-17

Lead Sponsor: Stanford University

Target Recruit Count: 160

Registration Number: NCT01899378

Locations: 🇧🇩
International Center for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh

Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma

Not Applicable

Completed

Conditions: Recurrent Melanoma

Interventions: Drug: Indocyanine green solution
Drug: Isosulfan blue (ISB)
Diagnostic Test: Lymphoscintigraphy with 99-technetium (99Tc) sulfur colloid (TSC)

First Posted Date: 2013-07-12

Last Posted Date: 2017-05-24

Lead Sponsor: Stanford University

Target Recruit Count: 50

Registration Number: NCT01898403

Locations: 🇺🇸
Stanford University Hospitals and Clinics, Stanford, California, United States

Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema

Not Applicable

Terminated

Conditions: Lymphedema
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: (RS)2-(3-benzoylphenyl)-propionic acid
Drug: placebo for study drug
Other: laboratory biomarker analysis

First Posted Date: 2013-07-09

Last Posted Date: 2017-05-18

Lead Sponsor: Stanford University

Target Recruit Count: 14

Registration Number: NCT01893879

Locations: 🇺🇸
Stanford University Hospitals and Clinics, Stanford, California, United States

Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms

Not Applicable

Completed

Conditions: Musculoskeletal Complications

Interventions: Dietary Supplement: levocarnitine
Other: placebo
Other: questionnaire administration

First Posted Date: 2013-07-09

Last Posted Date: 2017-08-04

Lead Sponsor: Stanford University

Target Recruit Count: 12

Registration Number: NCT01893892

Locations: 🇺🇸
Stanford University, School of Medicine, Stanford, California, United States

Evaluating Parent Delivered Interventions for Children With Autism

Not Applicable

Completed

Conditions: Autistic Disorder
Developmental Disabilities

Interventions: Behavioral: Pivotal Response Training (PRT)
Behavioral: PACE Therapy
Behavioral: PACE and PRT Hybrid

First Posted Date: 2013-06-20

Last Posted Date: 2023-07-14

Lead Sponsor: Stanford University

Target Recruit Count: 104

Registration Number: NCT01882153

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

A Study of Pregnenolone in the Treatment of Individuals With Autism

Phase 2

Completed

Conditions: Autistic Disorder

Interventions: Drug: Pregnenolone

First Posted Date: 2013-06-20

Last Posted Date: 2017-03-29

Lead Sponsor: Stanford University

Target Recruit Count: 15

Registration Number: NCT01881737

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Home Terms & Conditions Privacy Policy